nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A critical review of the role of M2PYK in the Warburg effect
|
Harris, Robert A. |
|
|
1871 |
2 |
p. 225-239 |
artikel |
2 |
Atomic force microscopy-based cancer diagnosis by detecting cancer-specific biomolecules and cells
|
Kwon, Taeyun |
|
|
1871 |
2 |
p. 367-378 |
artikel |
3 |
Combination therapies with HSP90 inhibitors against colorectal cancer
|
Kryeziu, Kushtrim |
|
|
1871 |
2 |
p. 240-247 |
artikel |
4 |
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer
|
Nowak-Sliwinska, Patrycja |
|
|
1871 |
2 |
p. 434-454 |
artikel |
5 |
Editorial Board
|
|
|
|
1871 |
2 |
p. ii |
artikel |
6 |
Exosomes in cancer development, metastasis, and immunity
|
Zhang, Lin |
|
|
1871 |
2 |
p. 455-468 |
artikel |
7 |
Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment
|
Wang, Manni |
|
|
1871 |
2 |
p. 199-224 |
artikel |
8 |
Many ways to resistance: How melanoma cells evade targeted therapies
|
Kozar, Ines |
|
|
1871 |
2 |
p. 313-322 |
artikel |
9 |
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
|
Liyanage, Piumi Y. |
|
|
1871 |
2 |
p. 419-433 |
artikel |
10 |
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
|
Cheng, Yuan |
|
|
1871 |
2 |
p. 289-312 |
artikel |
11 |
Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine
|
Strmiska, Vladislav |
|
|
1871 |
2 |
p. 248-258 |
artikel |
12 |
Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression
|
Amin, Sajid |
|
|
1871 |
2 |
p. 331-341 |
artikel |
13 |
Recent advances in extracellular vesicle research for urological cancers: From technology to application
|
Dong, Liang |
|
|
1871 |
2 |
p. 342-360 |
artikel |
14 |
Reflections on depletion of tumor stroma in pancreatic cancer
|
Wang, Wen-Quan |
|
|
1871 |
2 |
p. 267-272 |
artikel |
15 |
Rethinking pulmonary toxicity in advanced non-small cell lung cancer in the era of combining anti-PD-1/PD-L1 therapy with thoracic radiotherapy
|
Li, Mengqian |
|
|
1871 |
2 |
p. 323-330 |
artikel |
16 |
RLIP: An existential requirement for breast carcinogenesis
|
Singhal, Sharad S. |
|
|
1871 |
2 |
p. 281-288 |
artikel |
17 |
Targeting acidity in cancer and diabetes
|
Gillies, Robert J. |
|
|
1871 |
2 |
p. 273-280 |
artikel |
18 |
Targeting PI3K signaling in cancer: Challenges and advances
|
De Santis, Maria Chiara |
|
|
1871 |
2 |
p. 361-366 |
artikel |
19 |
Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway?
|
Yu, Xiang-Nan |
|
|
1871 |
2 |
p. 379-391 |
artikel |
20 |
The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
|
Parida, Sheetal |
|
|
1871 |
2 |
p. 392-405 |
artikel |
21 |
The role of necroptosis in cancer: A double-edged sword?
|
Qin, Xia |
|
|
1871 |
2 |
p. 259-266 |
artikel |
22 |
The small members of the JMJD protein family: Enzymatic jewels or jinxes?
|
Oh, Sangphil |
|
|
1871 |
2 |
p. 406-418 |
artikel |